Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
73 studies found for:    eye diseases AND university of iowa
Show Display Options
Rank Status Study
21 Completed Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Retinopathy of Prematurity;   Bronchopulmonary Dysplasia (BPD)
Interventions: Drug: Inositol lower volume;   Drug: Inositol mid-level volume;   Drug: Inositol high volume;   Drug: Placebo low volume
22 Recruiting A Phase 2 Study of RO6867461 in Participants With Center-Involving Diabetic Macular Edema (CI-DME) (BOULEVARD)
Condition: Diabetic Macular Edema
Interventions: Drug: RO6867461;   Drug: Ranibizumab;   Drug: Sham
23 Not yet recruiting Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
Conditions: Uveitis;   Macular Edema
Interventions: Drug: Dexamethasone intravitreal implant 0.7 mg;   Drug: Intravitreal Methotrexate 400 µg;   Drug: Intravitreal Ranibizumab 0.5 mg
24 Recruiting PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Conditions: Macular Edema;   Uveitis
Interventions: Drug: Periocular triamcinolone 40 mg;   Drug: Intravitreal triamcinolone 4 mg;   Drug: Dexamethasone intravitreal implant
25 Active, not recruiting Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery
Conditions: Recurrent Uveal Melanoma;   Stage III Uveal Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Cabozantinib S-malate;   Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis;   Drug: Temozolomide
26 Active, not recruiting Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Iris Melanoma;   Medium/Large Size Posterior Uveal Melanoma;   Ocular Melanoma With Extraocular Extension;   Recurrent Uveal Melanoma;   Small Size Posterior Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Drug: Selumetinib;   Drug: Temozolomide
27 Completed Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Conditions: Multiple Sclerosis;   Optic Neuritis;   Transverse Myelitis;   Acute Brainstem/Cerebellar Syndrome
Intervention: Drug: interferon beta 1a 30 ug IM once weekly
28 Active, not recruiting Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
Condition: Extraocular Retinoblastoma
Interventions: Procedure: autologous bone marrow transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Biological: filgrastim;   Drug: carboplatin;   Drug: vincristine sulfate;   Drug: thiotepa;   Radiation: radiation therapy
29 Recruiting International Guillain-Barré Syndrome Outcome Study
Conditions: Guillain-Barré Syndrome;   Miller Fisher Syndrome
Intervention:
30 Unknown  Longitudinal Optic Neuritis Study (LONS)
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Methylprednisolone;   Drug: Prednisone
31 Unknown  Optic Neuritis Treatment Trial (ONTT)
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Methylprednisolone;   Drug: Prednisone
32 Recruiting Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Condition: Cerebrotendinous Xanthomatosis (CTX)
Intervention:
33 Completed Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
Condition: Intraocular Retinoblastoma
Interventions: Drug: liposomal vincristine sulfate;   Drug: carboplatin;   Drug: etoposide
34 Recruiting Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Childhood Atypical Teratoid/Rhabdoid Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Oligodendroglioma;   Childhood Supratentorial Ependymoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma
Intervention: Other: cytology specimen collection procedure
35 Active, not recruiting Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
Conditions: Extraocular Retinoblastoma;   Intraocular Retinoblastoma;   Recurrent Retinoblastoma
Interventions: Other: questionnaire administration;   Other: laboratory biomarker analysis
36 Active, not recruiting Inflammation Inhibition in Prediabetic Humans
Conditions: Prediabetes;   Obese
Interventions: Drug: Salsalate;   Drug: Placebo
37 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
38 Completed
Has Results
Sudden Deafness Treatment Trial
Condition: Sudden Deafness
Interventions: Drug: prednisone;   Drug: methylprednisolone sodium succinate
39 Recruiting Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia (CML) to Characterize the Efficacy and Safety of a Range of Doses
Condition: Myeloid Leukemia, Chronic, Chronic Phase
Interventions: Drug: ponatinib 45 mg;   Drug: ponatinib 30 mg;   Drug: ponatinib 15 mg
40 Completed Vitamin A Equivalence of the Provitamin A in Biofortified Bananas
Condition: Vitamin A Deficiency
Intervention: Other: Provitamin A-biofortified transgenic bananas

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.